Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects

AIMS: The primary objective was to explore the pharmacodynamic changes during transition from rivaroxaban to warfarin in healthy subjects. Safety, tolerability and pharmacokinetics were assessed as secondary objectives. METHODS: An open label, non-randomized, sequential two period study. In treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Kenneth Todd, Byra, William, Vaidyanathan, Seema, Natarajan, Jaya, Ariyawansa, Jay, Salih, Hiba, Turner, Kenneth C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456123/
https://www.ncbi.nlm.nih.gov/pubmed/25475601
http://dx.doi.org/10.1111/bcp.12559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456123/
https://www.ncbi.nlm.nih.gov/pubmed/25475601
http://dx.doi.org/10.1111/bcp.12559

Ejemplares similares